Condition: Cognition · Brain Tumor · Magnetic Resonance Imaging · Sponsor: Universitaire Ziekenhuizen KU Leuven
The goal of this multicenter prospective longitudinal study is to study the long-term impact of multimodal treatment (chemotherapy, radiotherapy and surgery) in adult brain and base of skull tumors on neurocognitive functioning. All included patients will complete a self-report inventory (subjective cognitive functioning, QoL, confounders), a cognitive test battery, an advanced MR at multiple timepoints. Moreover, toxicity will be scored according to the CTCAEv5.0 in these patients over time.
This description comes directly from the study's public registry record.
Laurien De Roeck, MD · 016 34 76 00 · Laurien.deroeck@uzleuven.be
Maarten Lambrecht, MD PhD · 016 34 76 00 · Maarten.lambrecht@uzleuven.be
Always discuss trial participation with your own doctor first.
| University Hospitals Ghent | Ghent, Belgium | Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| Gasthuis Zusters Antwerpen | Wilrijk, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05727605